Strategies to quantify unspliced and multiply spliced mRNA expression in HIV-2 infection

Journal of Virological Methods

Volumn 175, Issue 1, 2011, Pages 38-45

  Soares, Rui S ^a   Matoso, Paula ^a   Calado, Marta ^a   Sousa, Ana E ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

AIDS; HIV 2; HIV 2 replication; Multiply spliced mRNA; One step RT qPCR; Unspliced mRNA

Indexed keywords

GAG PROTEIN; MESSENGER RNA; TRANSACTIVATOR PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IN VITRO STUDY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION REGULATION; VALIDATION PROCESS; VIRUS INACTIVATION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

CELLS, CULTURED; GENE PRODUCTS, GAG; GENE PRODUCTS, TAT; HIV-2; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 79957973835     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.04.012     Document Type: Article

References (41)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Andersson S., Norrgren H., da Silva Z., Biague A., Bamba S., Kwok S., Christopherson C., Biberfeld G., Albert J. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch. Intern. Med. 2000, 160:3286-3293.
3. Bagnarelli P., Valenza A., Menzo S., Sampaolesi R., Varaldo P.E., Butini L., Montroni M., Perno C.F., Aquaro S., Mathez D., Leibowitch J., Balotta C., Clementi M. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J. Virol. 1996, 70:7603-7613.
4. Battaglia S., Benzoubir N., Nobilet S., Charneau P., Samuel D., Zignego A.L., Atfi A., Brechot C., Bourgeade M.F. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 2009, 4:e4355.
5. Berry N., Ariyoshi K., Jobe O., Ngum P.T., Corrah T., Wilkins A., Whittle H., Tedder R. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Retroviruses 1994, 10:1031-1037.
6. Berry N., Ariyoshi K., Jaffar S., Sabally S., Corrah T., Tedder R., Whittle H. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1998, 1:457-468.
7. Brachtel E.F., Mascola J.R., Wear D.J., Ehrenberg P.K., Dayhoff D.E., Sanders-Buell E., Michael N.L., Frankel S.S. Demonstration of de novo HIV type 1 production by detection of multiply spliced and unspliced HIV type 1 RNA in paraffin-embedded tonsils. AIDS Res. Hum. Retroviruses 2002, 18:785-790.
8. Bustin S.A., Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Technol. 2004, 15:155-166.
9. Drylewicz J., Matheron S., Lazaro E., Damond F., Bonnet F., Simon F., Dabis F., Brun-Vezinet F., Chene G., Thiebaut R. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS 2008, 22:457-468.
10. Duvall M.G., Jaye A., Dong T., Brenchley J.M., Alabi A.S., Jeffries D.J., van der Sande M., Togun T.O., McConkey S.J., Douek D.C., McMichael A.J., Whittle H.C., Koup R.A., Rowland-Jones S.L. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 2006, 176:6973-6981.
11. Foxall R.B., Cortesao C.S., Albuquerque A.S., Soares R.S., Victorino R.M., Sousa A.E. Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1. J. Virol. 2008, 82:9795-9799.
12. Furtado M.R., Kingsley L.A., Wolinsky S.M. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. J. Virol. 1995, 69:2092-2100.
13. Gomes P., Taveira N.C., Pereira J.M., Antunes F., Ferreira M.O., Lourenco M.H. Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J. Clin. Microbiol. 1999, 37:453-456.
14. Hermankova M., Siliciano J.D., Zhou Y., Monie D., Chadwick K., Margolick J.B., Quinn T.C., Siliciano R.F. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J. Virol. 2003, 77:7383-7392.
15. Karlin S., Altschul S.F. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2264-2268.
16. Kim S.Y., Byrn R., Groopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 1989, 63:3708-3713.
17. Klotman M.E., Kim S., Buchbinder A., DeRossi A., Baltimore D., Wong-Staal F. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:5011-5015.
18. Kutyavin I.V., Afonina I.A., Mills A., Gorn V.V., Lukhtanov E.A., Belousov E.S., Singer M.J., Walburger D.K., Lokhov S.G., Gall A.A., Dempcy R., Reed M.W., Meyer R.B., Hedgpeth J. 3'-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 2000, 28:655-661.
19. Lekanne Deprez R.H., Fijnvandraat A.C., Ruijter J.M., Moorman A.F. Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal. Biochem. 2002, 307:63-69.
20. Mackewicz C.E., Patterson B.K., Lee S.A., Levy J.A. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J. Gen. Virol. 2000, 81:1261-1264.
21. MacNeil A., Sarr A.D., Sankale J.L., Meloni S.T., Mboup S., Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J. Virol. 2007, 81:5325-5330.
22. Marlink R., Kanki P., Thior I., Travers K., Eisen G., Siby T., Traore I., Hsieh C.C., Dia M.C., Gueye E.H., et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590.
23. Neumann M., Harrison J., Saltarelli M., Hadziyannis E., Erfle V., Felber B.K., Pavlakis G.N. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 1994, 10:1531-1542.
24. Pasternak A.O., Adema K.W., Bakker M., Jurriaans S., Berkhout B., Cornelissen M., Lukashov V.V. Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J. Clin. Microbiol. 2008, 46:2206-2211.
25. Pasternak A.O., Jurriaans S., Bakker M., Prins J.M., Berkhout B., Lukashov V.V. Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome. PLoS One 2009, 4:e8490.
26. Peccoud J., Jacob C. Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophys. J. 1996, 71:101-108.
27. Popper S.J., Sarr A.D., Travers K.U., Gueye-Ndiaye A., Mboup S., Essex M.E., Kanki P.J. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J. Infect. Dis. 1999, 180:1116-1121.
28. Popper S.J., Sarr A.D., Gueye-Ndiaye A., Mboup S., Essex M.E., Kanki P.J. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 2000, 74:1554-1557.
29. Ramalho A.S., Beck S., Farinha C.M., Clarke L.A., Heda G.D., Steiner B., Sanz J., Gallati S., Amaral M.D., Harris A., Tzetis M. Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts. J. Cyst. Fibros. 2004, 3(Suppl. 2):11-15.
30. Ranki A., Lagerstedt A., Ovod V., Aavik E., Krohn K.J. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 1994, 139:365-378.
31. Raymaekers M., Smets R., Maes B., Cartuyvels R. Checklist for optimization and validation of real-time PCR assays. J. Clin. Lab. Anal. 2009, 23:145-151.
32. Schwartz S., Felber B.K., Benko D.M., Fenyo E.M., Pavlakis G.N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 1990, 64:2519-2529.
33. Schwartz S., Felber B.K., Pavlakis G.N. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol. Cell. Biol. 1992, 12:207-219.
34. Simon F., Matheron S., Tamalet C., Loussert-Ajaka I., Bartczak S., Pepin J.M., Dhiver C., Gamba E., Elbim C., Gastaut J.A., et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.
35. Soares R., Foxall R., Albuquerque A., Cortesao C., Garcia M., Victorino R.M., Sousa A.E. Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection. J. Virol. 2006, 80:12425-12429.
36. Soares R.S., Tendeiro R., Foxall R.B., Baptista A.P., Cavaleiro R., Gomes P., Camacho R., Valadas E., Doroana M., Lucas M., Antunes F., Victorino R.M., Sousa A.E. Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. J. Virol. 2011, 85:2429-2438.
37. Soriano V., Gomes P., Heneine W., Holguin A., Doruana M., Antunes R., Mansinho K., Switzer W.M., Araujo C., Shanmugam V., Lourenco H., Gonzalez-Lahoz J., Antunes F. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J. Med. Virol. 2000, 61:111-116.
38. Stahlberg A., Hakansson J., Xian X., Semb H., Kubista M. Properties of the reverse transcription reaction in mRNA quantification. Clin. Chem. 2004, 50:509-515.
39. Toouli C.D., Turner D.R., Grist S.A., Morley A.A. The effect of cycle number and target size on polymerase chain reaction amplification of polymorphic repetitive sequences. Anal. Biochem. 2000, 280:324-326.
40. Wacker M.J., Godard M.P. Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J. Biomol. Technol. 2005, 16:266-271.
41. Wong M.L., Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.